business / news / / Devdiscourse
Novo Nordisk has teamed up with OpenAI to use artificial intelligence in its business.
Novo Nordisk is partnering with OpenAI to integrate AI across its drug development operations.
KEY POINTS
- The collaboration aims to use AI to analyse complex datasets and identify promising drug candidates.
- OpenAI's technology will help Novo Nordisk boost productivity and operational speed without replacing staff.
- Novo Nordisk is leveraging AI to regain market share after Eli Lilly's recent U.S. weight-loss drug approval.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →